Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Prediction and clinical utility of a contralateral breast cancer risk model

Fig. 2

Nomogram for the prediction of 5- and 10-year contralateral breast cancer cumulative incidence. The 5- and 10-year contralateral breast cancer cumulative incidence is calculated by taking the sum of the risk points, according to patient, first primary breast cancer tumor, and treatment characteristics. For each factor, the number of associated risk points can be determined by drawing a vertical line straight up from the factor’s corresponding value to the axis with risk points (0–100). The total points axis (0–350) is the sum of the factor’s corresponding values determined by every individual patient’s characteristics. Draw a line straight down from the total points axis to find the 5- and 10-year cumulative incidence.

PBC primary breast cancer, ER estrogen receptor status, HER2 human epidermal growth factor receptor 2, yr year

Back to article page